Trials / Completed
CompletedNCT00609531
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 10 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this proof of concept study is to use functional magnetic resonance imaging and behavioral assessments to investigate the effect of citalopram on restricted repetitive behaviors in people with autism spectrum disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Citalopram | Pill, 5-20mg once a day for twelve weeks |
| DRUG | Placebo | Placebo pill once a day for twelve weeks |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2008-02-07
- Last updated
- 2012-10-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00609531. Inclusion in this directory is not an endorsement.